Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Single-cell transcriptomics of alloreactive CD4+ T cells over time reveals divergent fates during gut graft-versus-host disease
Jessica A. Engel, Hyun Jae Lee, Cameron G. Williams, Rachel Kuns, Stuart Olver, Lianne I.M. Lansink, Megan S.F. Soon, Stacey B. Andersen, Joseph E. Powell, Valentine Svensson, Sarah A. Teichmann, Geoffrey R. Hill, Antiopi Varelias, Motoko Koyama, Ashraful Haque
Jessica A. Engel, Hyun Jae Lee, Cameron G. Williams, Rachel Kuns, Stuart Olver, Lianne I.M. Lansink, Megan S.F. Soon, Stacey B. Andersen, Joseph E. Powell, Valentine Svensson, Sarah A. Teichmann, Geoffrey R. Hill, Antiopi Varelias, Motoko Koyama, Ashraful Haque
View: Text | PDF
Research Article Hematology Immunology

Single-cell transcriptomics of alloreactive CD4+ T cells over time reveals divergent fates during gut graft-versus-host disease

  • Text
  • PDF
Abstract

Acute gastrointestinal (GI) graft-versus-host disease (GVHD) is a primary determinant of mortality after allogeneic hematopoietic stem cell transplantation (alloSCT). The condition is mediated by alloreactive donor CD4+ T cells that differentiate into pathogenic subsets expressing IFN-γ, IL-17A, or GM-CSF and is regulated by subsets expressing IL-10 and/or Foxp3. Developmental relationships between Th cell states during priming in mesenteric lymph nodes (mLNs) and effector function in the GI tract remain undefined at genome scale. We applied scRNA-Seq and computational modeling to a mouse model of donor DC-mediated GVHD exacerbation, creating an atlas of putative CD4+ T cell differentiation pathways in vivo. Computational trajectory inference suggested emergence of pathogenic and regulatory states along a single developmental trajectory in mLNs. Importantly, we inferred an unexpected second trajectory, categorized by little proliferation or cytokine expression, reduced glycolysis, and high tcf7 expression. TCF1hi cells upregulated α4β7 before gut migration and failed to express cytokines. These cells exhibited recall potential and plasticity following secondary transplantation, including cytokine or Foxp3 expression, but reduced T cell factor 1 (TCF1). Thus, scRNA-Seq suggested divergence of alloreactive CD4+ T cells into quiescent and effector states during gut GVHD exacerbation by donor DC, reflecting putative heterogeneous priming in vivo. These findings, which are potentially the first at a single-cell level during GVHD over time, may assist in examination of T cell differentiation in patients undergoing alloSCT.

Authors

Jessica A. Engel, Hyun Jae Lee, Cameron G. Williams, Rachel Kuns, Stuart Olver, Lianne I.M. Lansink, Megan S.F. Soon, Stacey B. Andersen, Joseph E. Powell, Valentine Svensson, Sarah A. Teichmann, Geoffrey R. Hill, Antiopi Varelias, Motoko Koyama, Ashraful Haque

×

Figure 6

Defining a cell-sorting strategy for TCF1hi TEa T cells.

Options: View larger image (or click on image) Download as PowerPoint
Defining a cell-sorting strategy for TCF1hi TEa T cells.
(A) bGPLVM visu...
(A) bGPLVM visualization of TEa cells from the mLN from day 1–4 expressing Il2ra and Cxcr6, with Slingshot trajectories overlaid. (B) Representative flow cytometry plots showing the expression of CD25, IFN-γ, IL-17A, and Foxp3 on Tcf1lo or Tcf1hi TEa cells from the mLN at day 4 after transfer, directly ex vivo, or after restimulation with PMA/ionomycin. (C) Graphs show the percentage of CD25+ or CD25– TEa cells that express IFN-γ, IL-17A and Foxp3. Data shown are combined from 2 independent experiments showing similar results (n = 9 mice). Statistical analysis was performed using a paired t test. *P < 0.05, **P ≤ 0.01, ***P ≤ 0.001, ****P ≤ 0.0001. (D) Representative flow cytometry plot showing the expression of CD25 and TCF1 on TEa cells from the mLN at day 4 after transfer. (E) Flow cytometry gating strategy used to isolate CD25–CXCR6– and CD25+CXCR6+ TEa cells from the mLN at day 4 after transfer. The corresponding purity checks and CTV expression for each population are shown. CTV, cell trace violet; mLN, mesenteric lymph node.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts